Journal
EXPERT REVIEW OF VACCINES
Volume 8, Issue 5, Pages 567-576Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERV.09.11
Keywords
cancer stem cells; cancer vaccine; dendritic cells; in vivo targeted vaccination; tolerance; xenoantigen
Categories
Ask authors/readers for more resources
Therapeutic vaccination against cancer is an important modality complementing current standard therapies and may lead to long-term control of cancer. Numerous strategies are in development in an attempt to achieve better effectiveness but, except for the recent advent of vaccines against human papillomavirus, the long effort to produce a cancer vaccine has not succeeded. Nevertheless, a number of novel approaches can be pursued that, in our view, include optimized antigen design, in vivo-targeted dendritic cell vaccination and cancer vaccines used in combination with chemotherapy, monoclonal antibodies, adoptive T-cell transfer or stem cell transplantation. This article summarizes the rationale and development of these approaches for improved cancer vaccines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available